FDA Inspection 1050123 — Siegfried Hameln GmbH

Siegfried Hameln GmbH — FEI 3002807877

The FDA completed an inspection of Siegfried Hameln GmbH on April 24, 2018 in Hameln. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 24, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hameln (Germany)